CD19 and non-Hodgkin lymphoma: To search for possible factors for CD19 CAR-T treatment in r/r NHL patients, we first performed univariate logistic regression analysis on patients’ clinical characteristics (Table 2), baseline hematological parameters (Table 3) and the first infusion of CAR-T cells (Supplementary Table 2).